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NeurologicalmanifestationsofGPAarecommon,mostfrequentlyasaperipheralneuropathy.Cerebritisasaprincipalpresentation
is extremely rare. We report a patient who presented with subacute progression of ataxia, confusion, and vacant episodes. An MRI
of her brain showed bilateral signal abnormalities in the cingulate and superior sagittal gyrus while a staging CT revealed a mass in
therightupperlobeofthepatient’slungwithasatellitenodule.C-ANCAantibodiesspecificforPR3athightitreswerepositiveand
a diagnosis of GPA was made. The patient was commenced on intravenous methylprednisolone followed by cyclophosphamide
and responded well to treatment. GPA is a rare and treatable differential diagnosis for confused patients with acute or subacute
neurological features and unusual MRI findings.
1. Introduction
Granulomatosiswithpolyangiitis(GPA),formerlyreferredto
as Wegener’s granulomatosis [1], is a vasculitis of the small
andmediumsizedvesselsofunknownaetiology.Itisstrongly
associated with cytoplasmic antineutrophil cytoplasmic anti-
bodies (c-ANCA) with PR3 specificity [2] and can affect any
organ, though it is particularly linked to the kidneys and
respiratory tract. Neurological manifestations are common,
affecting up to a third of patients. However, cerebritis is a
veryrarepresentation,tworeportsofwhicharethedefinitive
studies of neurological involvement in GPA by Nishino et al.
[3, 4]( af o u r t hc a s ee x c l u d e sW e g e n e r ’ sg r a n u l o m a t o s i sa sa
differential when diagnosing cocaine-induced encephalocele
[5]). This case report details a patient whose only presenting
symptoms were secondary to cerebritis.
2. Case Report
A 64-year-old Caucasian woman presented to her local
districtgeneralhospitalwithasubacuteprogressionofataxia,
initially diagnosed in the community as labyrinthitis. Her
p a s tm e d i c a lh i s t o ryw a so n l yn o t a b l ef o rat h y r o i d e c t o m yi n
1993 for a papillary carcinoma, which was considered cured
at subsequent follow-up. Her only regular medication was
thyroxin and she had no allergies, occupational exposure to
hazardous materials, or family history of note. She neither
smoked nor drank alcohol.
Upon transfer to our hospital, clinical examination
demonstrated marked confusion, ataxia, and horizontal nys-
tagmus; power, muscle tone, and deep tendon reflexes were
normal. There were no significant chest, abdominal, or other
physical findings and temperature was normal. An MRI
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Figure 1: Imaging at presentation (08/2012). (a) Axial T2 image demonstrating moderate parafalcine oedema with local mass effect. (b)
Axial apparent diffusion coefficient map confirming free water diffusion, that is, vasogenic oedema. (c) Coronal T1 postcontrast image
demonstrating avid parafalcine leptomeningeal and cortical enhancement.
of her brain showed bilateral parenchymal oedema and
leptomeningeal/cortical enhancement associated with the
cingulate and superior sagittal gyrus (Figure 1). A lumbar
puncture revealed opening CSF pressure >34cm H2O( t h e
maximum value on the manometers used) with reactive
cytology (although no white blood cells were detected upon
automatic counting, cytospin analysis revealed lymphocytes
and plasma cells together with macrophages and an occa-
sional eosinophil; no neoplastic cells were observed) and
raised CSF protein (742mg/L). A staging CT revealed a mass
in the right upper lobe of the patient’s lung with a satellite
nodule (image not shown) and a plan for CT guided biopsy
was made. Serum angiotensin converting enzyme was nor-
mal and an electroencephalogram showed no epileptiform
activity.
Detailed questioning by the rheumatologist elicited a
history of two years of joint pain responsive to NSAIDs, two
episodes of an inflammatory eye disease (likely episcleritis)
treated successfully with topical steroids, and intermittent
nose bleeds, though none recent. A provisional diagnosis
of GPA was suggested, with differential diagnoses including
infection(particularlytuberculosis)andcancer,possiblywith
a paraneoplastic syndrome. However, strongly positive c-
ANCA specific for PR3 suggested a vasculitic condition and
the patient was commenced on intravenous methylpred-
nisolone, with an early good clinical response in terms of
both limb power and improved higher cognitive function.
In terms of differential diagnosis, the absence of elevated
ACE and calcium, typical lung parenchymal changes, cranial
neuropathies or seizures, signs of myelopathy, radiculopa-
thy, peripheral neuropathy, or neuroendocrine dysfunction
(hypothyroidism was due to previous thyroidectomy) did
not support a diagnosis of sarcoidosis. Cerebrospinal fluid
analysis did not show either acid-fast bacilli or growth of
Mycobacteria; the lung abnormalities were not suggestive
of tuberculosis. Meningeal carcinosis was unlikely in the
absence of detectable systemic primary tumours, in partic-
ular, breast and melanoma (negative clinical examination)
andlung(parenchymallesionsnotsuggestiveoflungcancer).
In addition, cerebrospinal fluid cytology did not show any
cancerous cells.
Following the third dose of IV steroids, the patient
became extremely confused and complained of chest pain,
withclinicalfindingsoftachycardia,tachypnea,hypotension,
and desaturation on room air. Serial electrocardiograms
demonstrated anterior ST depression and T wave inversion
extending inferiorly. Troponin I was transiently elevated to
0.110𝜇g/L. An arterial blood gas showed type 1 respiratory
failure. The patient was transferred from the neurology
ward to the coronary care unit, though the cardiology team
were unconvinced that the ECG changes represented acute
coronary syndrome. An urgent CTPA did not identify a
pulmonary embolus, and coronary arteries were patent.
However, interval cavitation in the right upper lobe mass
lesion was demonstrated. A subsequent echocardiogram was
also normal. These features in association with positivity for
c-ANCA and the presence of anti-proteinase 3 antibodies at
hightitre(39U/mL;reference0–5U/mL),alongsidenegative
cultures for microorganisms of the patient’s CSF, blood,
urine,andotherpotentialsourcesofinfection,confirmedthe
diagnosis of GPA [6, 7].
The patient was commenced on aspirin and clopidogrel
alongsideIVheparin.Thepatient’sconfusionandimmobility
had persisted to this point, while her ECGs had returned to
normal as had her heart rate and respiratory function. Since
she lacked capacity to consent at the time, after discussion
withherfamily,itwasdecidedthatmoreaggressiveimmuno-
suppressive treatment would be in her best interest.
A rapid clinical response to the intravenous cyclophos-
phamide therapy was observed [8] and radiological intracra-
nial features demonstrated improvement (Figure 2). Within
days of starting cyclophosphamide therapy the patient had
a remarkable recovery of cognitive function. She was dis-
charged to outpatient care under rheumatology and neurol-
ogy with a referral to her local hospital for rehabilitation
and physiotherapy. With regard to nonspecific markers of
inflammation, initial peripheral blood values were CRP
53mg/L (peak value 106mg/L), WBC counts 14.2 × 10
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Figure 2: Imaging 5 weeks after presentation, following 3 pulses of methylprednisolone and 2 cycles of IV cyclophosphamide (09/2012). (a)
Axial T2 demonstrates substantial resolution of parafalcine oedema. (b) Coronal T1 postcontrast image demonstrates reduction in extent and
degree of enhancement in comparison with Figure 1(c).
(a) (b)
Figure 3: Imaging 9 months after presentation, following 10 cycles of IV cyclophosphamide therapy (05/2013). (a) Axial T2 demonstrates
progressive parafalcine oedema, mass effect, and subtle cortical haemorrhage. (b) Coronal T1 postcontrast image demonstrates progressive
avid leptomeningeal enhancement, cortical swelling, and avid enhancement of progressively thickened dura.
(peak value 23.5 × 10
9/L), and neutrophils 10.7 × 10
9/L (peak
value 20.7 × 10
9/L); haemoglobin remained in the normal
range.
Treatmentwasgivenwithintravenouscyclophosphamide
pulses (at 15mg/kg, initially every 2 and then every 4 weeks,
withoutdosealterationsaskidneyfunctionwasnormal)with
a plan to switch treatment to oral methotrexate after the
10th infusion. Repeat imaging 9 months after presentation
was performed shortly after discontinuation of cyclophos-
phamide and a few weeks before methotrexate could be
initiated, a delay caused by a respiratory infection, treated
with cotrimoxazole, which interacts with methotrexate. At
the time, there was mild cognitive deterioration and imaging
demonstrated radiological progression of the underlying
diseaseprocess(Figure 3).However,otherclinicalandobjec-
tive measures of disease activity (including inflammatory
markers and BVAS scores [9]) remained stable. Therefore,
methotrexate was introduced as planned. Further imaging 12
months after presentation and after 3 months of treatment
with methotrexate showed partial improvement in the extent
of T2 abnormality and oedema (Figure 4). Further improve-
ment was documented 6 months after the scan presented in
Figure 4 (not shown).
3. Discussion
GPA is an autoimmune vasculitis of unknown aetiology. It
affects the small and medium vessels causing granulomatous
lesions. Prior to the development of immunosuppressive
therapy, it had an extremely high rate of mortality, but five-
y e a rs u r v i v a li sn o wa sh i g ha s9 0 % ,a l b e i tw i t ha4 0 %r i s k
of flare-ups and no cure is available yet [10]. The mainstay of
treatment for GPA is cyclophosphamide, a potent nitrogen
mustard alkylating agent. There is strong evidence that the
benefit of cyclophosphamide therapy outweigh the risks of
this medication [8, 11].4 Case Reports in Neurological Medicine
Figure 4: Further axial T2 study 3 months later (08/2013) showing
some improvement in extent of T2 abnormality and oedema; dural
thickening and enhancement persist.
The diagnostic criteria from the American College of
Rheumatology are particularly useful to identify patients
for research purposes [12], but the mainstay of diagnosis is
clinical suspicion with positive PR3 c-ANCA tests [2], which
are highly specific for GPA. Neurological manifestations are
common, as identified in a landmark paper by Nishino et al.
in 1993 [3], but cerebritis is the rarest of these manifestations
and particularly unusual as the initial means of presentation.
This patient presented with neurological manifestations
o n l ya n dw a sf o u n dt oh a v ei n t r a c r a n i a ll e s i o n sw i t hp a c h y -
meningitis and cerebritis. In retrospect, the symmetry of the
lesions suggested vasculitis, but her normal renal function
and lack of involvement of other systems, prior to the CT
scan, argued against GPA.
A primary astrocytoma or a meningeal metastasis was
among the top initial differential diagnoses, especially with
the discovery of an isolated lesion in the lung, but when the
C S Fw a sf o u n dt ob er e a c t i v e ,i n f e c t i o na l s oh a dt ob ec o n -
sidered. The absence of pyrexia throughout the admission
suggested that if infection was responsible it was unlikely
to be a typical organism, with concerns raised about the
possibility of tuberculosis, particularly when high dose IV
steroids were suggested as a treatment.
With the confirmed anti-PR3 c-ANCA and the initial
improvement on IV steroids, the diagnosis of vasculitis
became the likeliest explanation for the patient’s symptoms,
including the lung lesion, now cavitating, and the symmet-
rical lesions in the brain. Prompt input from rheumatology
was very valuable in confirming the diagnosis as an exclusive
CNSpresentationofGPAissorare.Pulmonaryabnormalities
were detected radiologically but were not part of the clinical
presentation. This case underscores the need to maintain a
thorough differential diagnosis and the benefit of opinions
from other specialities early in the investigative process.
Inconclusion,thepatientwasadmittedwithneurological
manifestations of a systemic vasculitis. The diagnosis pre-
sented difficulties due to the rarity of this clinical appearance
asaprimarypresentationofGPA.Adequateinvestigationand
promptinputfromanumberofspecialities,includingneurol-
ogy, neurosurgery, rheumatology, cardiology, biochemistry,
and immunology, offered a strong basis for commencing
c h e m o t h e r a p ya n da l l o w e dt h en e a rc o m p l e t ec l i n i c a lr e c o v -
ery of a patient who had appeared to be deteriorating
u n r e m i t t i n g l y .An o t eo fc a u t i o ni sw a r r a n t e di nc o n s i d e r a -
tion of slower and less marked radiological recovery, indicat-
ingthat continuingunderlyinginflammationmaylag behind
clinical improvement and that continued monitoring and
immunosuppression are essential. This case report should be
useful to highlight an unusual presentation of GPA and the
need to consider such condition in the differential diagnosis
of encephalopathic presentations of neurological disease.
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